OBJECTIVE: To present current strategies for the treatment of hemophilia and von
Willebrand9s disease. OPTIONS: Prophylactic and corrective therapy with hemostatic and …

The optimal treatment of patients with von Willebrand's disease (vWD) remains to be
defined. Moreover, it has not been firmly established which, if any, commonly measured …

The Treatment of Hemophilia series is intended to provide general information on the
treatment and management of hemophilia. The World Federation of Hemophilia does not …

A variety of haemostatic agents can be helpful for patients with von Willebrand disease in
case of bleeding. There are orally administered substances, such as tranexamic acid …

While certain plasma‐derived factor VIII/von Willebrand factor (FVIII/vWF) concentrates have
proven to be quite useful in preventing or controlling bleeding in persons with von …

von Willebrand disease (VWD) is the commonest inherited bleeding disorder. The aim of
therapy for VWD is to correct the two defects of haemostasis in this disorder, impaired …

In 1997 the UK Haemophilia Centre Directors Organization published the guidelines for
diagnosis and management of von Willebrand disease (vWD). The guidelines stated that …

Inhibitor formation is among the most serious complications of hemophilia treatment, being
estimated to occur in 25% or more of those with hemophilia A [1]. Inhibitor formation is a T …

Hemophilia of Georgia, Inc., and the Hemophilia Treatment Centers of Georgia have
combined resources and expertise to develop guidelines for physicians who treat patients …

Provides overview of articles on Von Willebrand's disease, published in the October 2, 2004
issue of" Haemophilia."" Clinical Diagnosis of Von Willebrand Diseases," by A. Federici;" …